Cargando…

PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer

Purpose: Long noncoding RNAs (lncRNAs) have been demonstrated as effective markers for cancer detection and prognosis prediction. The aim of this study was to determine whether tissue PART1 could be used as a biomarker for prognosis prediction of non-small cell lung cancer (NSCLC). Methods: PART1 ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ming, Zhang, Weiwei, Zhang, Shenjun, Wang, Changhui, Lin, Yinping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556642/ https://www.ncbi.nlm.nih.gov/pubmed/28819376 http://dx.doi.org/10.7150/jca.18848

Ejemplares similares

PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction
por: Li, Ming, et al.
Publicado: (2023)

Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3
por: Li, Ming, et al.
Publicado: (2016)

Retraction Note: Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3
por: Li, Ming, et al.
Publicado: (2021)

Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2020)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Independent factors FOR poor prognosis in young patients with stage I-III breast cancer
por: Erić, Ivan, et al.
Publicado: (2020)

Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma
por: Fu, Tao, et al.
Publicado: (2016)

Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer
por: Kong, Peng-Zhou, et al.
Publicado: (2016)

Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I–III Non-Small Cell Lung Cancer
por: Grossi, Francesco, et al.
Publicado: (2015)

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer
por: Wang, Jun, et al.
Publicado: (2016)

FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III
por: Jiang, Minlin, et al.
Publicado: (2021)

Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis
por: Katsui, Kuniaki, et al.
Publicado: (2021)

High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis
por: Cha, Geqi, et al.
Publicado: (2017)

Squalene synthase predicts poor prognosis in stage I‐III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression
por: Jiang, Huihong, et al.
Publicado: (2022)

Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma
por: Deng, Yujie, et al.
Publicado: (2022)

CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer
por: Nam, Yunha, et al.
Publicado: (2022)

Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2021)

Impact of idiopathic pulmonary fibrosis on recurrence after surgical treatment for stage I–III non-small cell lung cancer
por: Song, Myung Jin, et al.
Publicado: (2020)

Publisher Correction: Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis
por: Katsui, Kuniaki, et al.
Publicado: (2021)

Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I–III Non-small Cell Lung Cancer Patients
por: Dong, Jingsi, et al.
Publicado: (2019)

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

Immunomodulatory effects of intestinal lung axis microecology and other factors on the prognosis of advanced non-small cell lung cancer
por: Shen, Changxing, et al.
Publicado: (2019)

Expression and prognosis of inducible T‐cell co‐stimulator and its ligand in Chinese stage I–III lung adenocarcinoma patients
por: Zhan, Xiao‐Kai, et al.
Publicado: (2023)

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
por: Cheng, Xiaojing, et al.
Publicado: (2015)

A chromosomal passenger complex protein signature model predicts poor prognosis for non-small-cell lung cancer
por: Xia, Rong, et al.
Publicado: (2015)

Prognosis of Recurrence after Complete Resection in Early-Stage Non-Small Cell Lung Cancer
por: Choi, Pil Jo, et al.
Publicado: (2013)

Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma
por: Hu, Di, et al.
Publicado: (2022)

Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma
por: Luo, Jizhuang, et al.
Publicado: (2016)

Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I–III lung adenocarcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2022)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

Combined neat model for the prognosis of postoperative stage III‐N2 non‐small cell lung cancer
por: Zhai, Yirui, et al.
Publicado: (2020)

Gene-Expression Signature Predicts Postoperative Recurrence in Stage I Non-Small Cell Lung Cancer Patients
por: Lu, Yan, et al.
Publicado: (2012)

Early recurrence factors in patients with stage III non‐small cell lung cancer treated with concurrent chemoradiotherapy
por: Takahara, Yutaka, et al.
Publicado: (2022)

Lobar emphysema ratio of more than 1% in the lobe with lung cancer as poor predictor for recurrence and overall survival in patients with stage I non-small cell lung cancer
por: Lee, Jeong Pyo, et al.
Publicado: (2023)

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group
por: Strøm, H H, et al.
Publicado: (2013)

Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer
por: Ma, Jun, et al.
Publicado: (2017)

Recurrence Risk Factors Analysis for Stage I Non-small CellLung Cancer: Erratum
Publicado: (2015)

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Cho, Su Han, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cqmjcmv5e3n2rlgikdutga90ul